Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Clinical trial NCT03393000 · TERMINATED
Trial details
- NCT number
- NCT03393000
- Sponsor
- Diffusion Pharmaceuticals Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-16
- Primary completion
- 2020-11-06
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.